MedTrace Logo

DIV-AD BARCELONA: Alzheimer's Blood-Based Biomakers for a Diverse Community

NCT07521722 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 250

Last updated 2026-04-13

No results posted yet for this study

Summary

The DIV-AD study aims to find out whether levels of Alzheimer's disease markers in blood differ among the main ethnical groups living in central Barcelona.

It will also examine how factors such as age, income, education, and health conditions may affect these levels.

In addition, the study will identify barriers that may make it difficult to use these blood tests in primary care.

The final goal is to help ensure that everyone in Barcelona has fair access to early prevention strategies for Alzheimer's disease.

Conditions

  • Alzheimer Disease
  • Cognitive Dysfunction, Cognitive Disorder
  • Dementia
  • Neurodegenerative Disease

Sponsors & Collaborators

  • Universitat Pompeu Fabra

    collaborator OTHER

  • Hospital del Mar Research Institute (IMIM)

    collaborator OTHER

  • Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina

    collaborator OTHER

  • Hospital del Mar

    collaborator OTHER

  • Barcelonabeta Brain Research Center, Pasqual Maragall Foundation

    lead OTHER

Eligibility

Min Age
50 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-04-27
Primary Completion
2027-04-27
Completion
2029-01-01

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07521722 on ClinicalTrials.gov